Abstract

Neutrophil extracellular traps (NETs) are web-like structures released by activated neutrophils. Recent studies suggest that NETs play an active role in driving autoimmunity and tissue injury in diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The purpose of this study was to investigate if celastrol, a triterpenoid compound, can inhibit NET formation induced by inflammatory stimuli associated with RA and SLE. We found that celastrol can completely inhibit neutrophil oxidative burst and NET formation induced by tumor necrosis factor alpha (TNFα) with an IC50 of 0.34 μM and by ovalbumin:anti-ovalbumin immune complexes (Ova IC) with an IC50 of 1.53 μM. Celastrol also completely inhibited neutrophil oxidative burst and NET formation induced by immunoglobulin G (IgG) purified from RA and SLE patient sera. Further investigating into the mechanisms, we found that celastrol treatment downregulated the activation of spleen tyrosine kinase (SYK) and the concomitant phosphorylation of mitogen-activated protein kinase kinase (MAPKK/MEK), extracellular-signal-regulated kinase (ERK), and NFκB inhibitor alpha (IκBα), as well as citrullination of histones. Our data reveals that celastrol potently inhibits neutrophil oxidative burst and NET formation induced by different inflammatory stimuli, possibly through downregulating the SYK-MEK-ERK-NFκB signaling cascade. These results suggest that celastrol may have therapeutic potentials for the treatment of inflammatory and autoimmune diseases involving neutrophils and NETs.

Original languageEnglish (US)
Pages (from-to)401-410
Number of pages10
JournalCurrent Molecular Medicine
Volume15
Issue number4
DOIs
StatePublished - Jan 1 2015

Fingerprint

Mitogen-Activated Protein Kinase Kinases
Neutrophils
Respiratory Burst
Systemic Lupus Erythematosus
Extracellular Signal-Regulated MAP Kinases
Ovalbumin
Rheumatoid Arthritis
Protein-Tyrosine Kinases
Inhibitory Concentration 50
Down-Regulation
Phosphorylation
Antigen-Antibody Complex
Histones
tripterine
Extracellular Traps
Autoimmunity
Autoimmune Diseases
Tumor Necrosis Factor-alpha
Immunoglobulin G
Chemical activation

Keywords

  • Arthritis
  • Celastrol
  • Inflammation
  • Lupus
  • Neutrophil extracellular trap

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation. / Yu, Y.; Koehn, C. D.; Yue, Y.; Li, S.; Thiele, Geoffrey Milton; Hearth-Holmes, Michelene P; Mikuls, Ted R; O'Dell, James Robert; Klassen, Lynell Warren; Zhang, Z.; Su, Kaihong.

In: Current Molecular Medicine, Vol. 15, No. 4, 01.01.2015, p. 401-410.

Research output: Contribution to journalArticle

@article{d600caa903b14bdab805cc2d95f2a2d4,
title = "Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation",
abstract = "Neutrophil extracellular traps (NETs) are web-like structures released by activated neutrophils. Recent studies suggest that NETs play an active role in driving autoimmunity and tissue injury in diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The purpose of this study was to investigate if celastrol, a triterpenoid compound, can inhibit NET formation induced by inflammatory stimuli associated with RA and SLE. We found that celastrol can completely inhibit neutrophil oxidative burst and NET formation induced by tumor necrosis factor alpha (TNFα) with an IC50 of 0.34 μM and by ovalbumin:anti-ovalbumin immune complexes (Ova IC) with an IC50 of 1.53 μM. Celastrol also completely inhibited neutrophil oxidative burst and NET formation induced by immunoglobulin G (IgG) purified from RA and SLE patient sera. Further investigating into the mechanisms, we found that celastrol treatment downregulated the activation of spleen tyrosine kinase (SYK) and the concomitant phosphorylation of mitogen-activated protein kinase kinase (MAPKK/MEK), extracellular-signal-regulated kinase (ERK), and NFκB inhibitor alpha (IκBα), as well as citrullination of histones. Our data reveals that celastrol potently inhibits neutrophil oxidative burst and NET formation induced by different inflammatory stimuli, possibly through downregulating the SYK-MEK-ERK-NFκB signaling cascade. These results suggest that celastrol may have therapeutic potentials for the treatment of inflammatory and autoimmune diseases involving neutrophils and NETs.",
keywords = "Arthritis, Celastrol, Inflammation, Lupus, Neutrophil extracellular trap",
author = "Y. Yu and Koehn, {C. D.} and Y. Yue and S. Li and Thiele, {Geoffrey Milton} and Hearth-Holmes, {Michelene P} and Mikuls, {Ted R} and O'Dell, {James Robert} and Klassen, {Lynell Warren} and Z. Zhang and Kaihong Su",
year = "2015",
month = "1",
day = "1",
doi = "10.2174/1566524015666150505160743",
language = "English (US)",
volume = "15",
pages = "401--410",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation

AU - Yu, Y.

AU - Koehn, C. D.

AU - Yue, Y.

AU - Li, S.

AU - Thiele, Geoffrey Milton

AU - Hearth-Holmes, Michelene P

AU - Mikuls, Ted R

AU - O'Dell, James Robert

AU - Klassen, Lynell Warren

AU - Zhang, Z.

AU - Su, Kaihong

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Neutrophil extracellular traps (NETs) are web-like structures released by activated neutrophils. Recent studies suggest that NETs play an active role in driving autoimmunity and tissue injury in diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The purpose of this study was to investigate if celastrol, a triterpenoid compound, can inhibit NET formation induced by inflammatory stimuli associated with RA and SLE. We found that celastrol can completely inhibit neutrophil oxidative burst and NET formation induced by tumor necrosis factor alpha (TNFα) with an IC50 of 0.34 μM and by ovalbumin:anti-ovalbumin immune complexes (Ova IC) with an IC50 of 1.53 μM. Celastrol also completely inhibited neutrophil oxidative burst and NET formation induced by immunoglobulin G (IgG) purified from RA and SLE patient sera. Further investigating into the mechanisms, we found that celastrol treatment downregulated the activation of spleen tyrosine kinase (SYK) and the concomitant phosphorylation of mitogen-activated protein kinase kinase (MAPKK/MEK), extracellular-signal-regulated kinase (ERK), and NFκB inhibitor alpha (IκBα), as well as citrullination of histones. Our data reveals that celastrol potently inhibits neutrophil oxidative burst and NET formation induced by different inflammatory stimuli, possibly through downregulating the SYK-MEK-ERK-NFκB signaling cascade. These results suggest that celastrol may have therapeutic potentials for the treatment of inflammatory and autoimmune diseases involving neutrophils and NETs.

AB - Neutrophil extracellular traps (NETs) are web-like structures released by activated neutrophils. Recent studies suggest that NETs play an active role in driving autoimmunity and tissue injury in diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The purpose of this study was to investigate if celastrol, a triterpenoid compound, can inhibit NET formation induced by inflammatory stimuli associated with RA and SLE. We found that celastrol can completely inhibit neutrophil oxidative burst and NET formation induced by tumor necrosis factor alpha (TNFα) with an IC50 of 0.34 μM and by ovalbumin:anti-ovalbumin immune complexes (Ova IC) with an IC50 of 1.53 μM. Celastrol also completely inhibited neutrophil oxidative burst and NET formation induced by immunoglobulin G (IgG) purified from RA and SLE patient sera. Further investigating into the mechanisms, we found that celastrol treatment downregulated the activation of spleen tyrosine kinase (SYK) and the concomitant phosphorylation of mitogen-activated protein kinase kinase (MAPKK/MEK), extracellular-signal-regulated kinase (ERK), and NFκB inhibitor alpha (IκBα), as well as citrullination of histones. Our data reveals that celastrol potently inhibits neutrophil oxidative burst and NET formation induced by different inflammatory stimuli, possibly through downregulating the SYK-MEK-ERK-NFκB signaling cascade. These results suggest that celastrol may have therapeutic potentials for the treatment of inflammatory and autoimmune diseases involving neutrophils and NETs.

KW - Arthritis

KW - Celastrol

KW - Inflammation

KW - Lupus

KW - Neutrophil extracellular trap

UR - http://www.scopus.com/inward/record.url?scp=84930986439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930986439&partnerID=8YFLogxK

U2 - 10.2174/1566524015666150505160743

DO - 10.2174/1566524015666150505160743

M3 - Article

C2 - 25941817

AN - SCOPUS:84930986439

VL - 15

SP - 401

EP - 410

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 4

ER -